The Current and Future Role of Immuno-Oncologic Agents in Early-Stage, Locally Advanced, and Metastatic NSCLC
Host: Debora Bruno, MD
\n\n Guest: Gilberto de Lima Lopes, Jr, MD, MBA, FASCO
\n\n Guest: Solange Peters, MD, PhD
\n\n\n \n
Immuno-oncologic agents have changed the treatment landscape for non-small cell lung cancer. Listen in as Drs. Debora Bruno, Gilberto Lopes, and Solange Peters discuss the most recent data for immunotherapy in early-stage, locally advanced, and metastatic NSCLC.